Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Albany Molecular Research Inc. (AMRI) and Icagen, Inc. have signed a collaboration agreement to co-market Icagen's ion channel and transporter technology to global pharmaceutical and biotechnology clients.
read more
Thursday, December 10, 2015
Albany Molecular Research Inc. (AMRI) has signed a collaboration agreement with biotechnology company Multispan Inc. to co-market their G protein-coupled receptor (GPCR) drug discovery services to global pharmaceutical and biotechnology clients.
read more
Thursday, January 14, 2016
Albany Molecular Research Inc. (AMRI) has signed a collaboration agreement with the New York Center for Nanomedicine Research (NYCNMR) to co-market their nanotechnology services to global pharmaceutical and biotechnology clients.
read more
Albany, NY (April 23, 2013) — AMRI announced today that it has entered into a new five-year service agreement with Ono Pharmaceutical Company, Ltd., (TSE: 4528), a pharmaceutical company headquartered in Osaka, Japan. Under the terms of the agreement...
read more
Wednesday, January 13, 2016
AMRI has announced the extension of a key insourcing relationship with a major pharmaceutical company designed to accelerate their chemistry and drug discovery efforts.
read more
Tuesday, February 21, 2017
AMRI has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare, Inc. to jointly develop and manufacture an undisclosed complex parenteral drug product for registration and subsequent commercialization in the United ...
read more
Tuesday, November 29, 2016
AMRI has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, Inc. which product has been in AMRI's portfolio through the required stages of development.
read more
AMRI, a leading global contract research and manufacturing organization, has announced that the Board of Directors has unanimously voted to separate the role of Chairman and Chief Executive Officer and has named William S. Marth, an active member of ...
read more
Monday, December 09, 2019
AMRI announced John Ratliff has been named as chief executive officer, effective today, Dec. 2, 2019.
read more
AMRI has announced the appointment of Prakash Pandian as chief information officer.
read more
AMRI reported financial and operating results for the first quarter ended March 31, 2017 and provided an update to its outlook for 2017.
read more
AMRI announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing Inc., whose parent company, Shire plc, is a global company that focuses its business on behavioral health, gastro ...
read more
Wednesday, February 17, 2016
AMRI has reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an outlook for 2016.
read more
Wednesday, February 10, 2021
AMRI has announced the appointment of Scott Waldman as senior vice president, corporate development.
read more
AMRI announces its new multipurpose aseptic API line at the company’s facility in Valladolid, Spain.
read more